Medical Affairs teams have emerged as key players not only in advancing the success of their companies, but also in helping to improve patient outcomes. Underpinning this role is their ability to engage customers—especially key external experts—effectively via different channels and activities.
One key to successful KEE engagement is the alignment of tactical execution to a broader corporate/medical strategy. Once the broader strategic imperatives are clear, Medical Affairs (and other departments) can use them to guide their strategic decisions related to KEE engagement and utilization. Clear strategic intent, when coupled with technology allows organizations to make more focused expert selection and utilization decisions spanning the commercialization process of a compound and beyond.
In this webinar, we will discuss how technology has aided Life Sciences leaders as they engage with experts at various stages of the product life cycle from identifying clinical investigators, preparing for a launch and developing focus for a new field medical team(s).